Insider · CIK 0002050895
Forbion Growth Opportunities Fund III Cooperatief U.A.
Files at BRVE (Braveheart Bio, Inc.). First filing Aug 7, 2026, latest Aug 7, 2026.
In brief
Forbion Growth Opportunities Fund III Cooperatief U.A. files SEC Form 4 as 10% owner at BRVE (Braveheart Bio, Inc.). Since Aug 7, 2026, Forbion Growth Opportunities Fund III Cooperatief U.A. has reported 1 open-market buy worth $65M and 0 open-market sells worth $0, the latest filed on Aug 7, 2026.
A track record needs three past buys with six months of prices behind them; Forbion Growth Opportunities Fund III Cooperatief U.A. has 0, so none is measured yet.
The newest scored trade: bought $65M of BRVE on Aug 7, 2026, filed Aug 7, 2026, scored 53 (moderate). In the last 12 months: 1 buy worth $65M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BRVE: Braveheart Bio, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | Braveheart Bio, Inc. | $65M 3,600,000 shares | +37% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | CConversion Common Stock | +9,132,420 | $0.00 | $0 | 9,720,546 | Aug 7, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | CConversion Common Stockindirect: By Forbion Ventures Fund VII Cooperatief U.A. | +7,990,867 | $0.00 | $0 | 8,505,478 | Aug 7, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | POpen-market purchase Common Stock | +1,920,000 | $18.00 | $35M | 11,640,546 | Aug 7, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | POpen-market purchase Common Stockindirect: By Forbion Ventures Fund VII Cooperatief U.A. | +1,680,000 | $18.00 | $30M | 10,185,478 | Aug 7, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | CConversion Series A Preferred Stockderivative | -40,000,000 | $0.00 | $0 | 0 | Aug 7, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | CConversion Series A Preferred Stockderivativeindirect: By Forbion Ventures Fund VII Cooperatief U.A. | -35,000,000 | $0.00 | $0 | 0 | Aug 7, 2026 |
Questions about Forbion Growth Opportunities Fund III Cooperatief U.A.
Answered from the filings on this page, as of the latest one.
Is Forbion Growth Opportunities Fund III Cooperatief U.A. buying or selling?
In the last 12 months Forbion Growth Opportunities Fund III Cooperatief U.A. reported 1 open-market buy worth $65M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $65M of BRVE on Aug 7, 2026. Grants, option exercises and tax withholding are not counted.
How did Forbion Growth Opportunities Fund III Cooperatief U.A.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Forbion Growth Opportunities Fund III Cooperatief U.A. has 0.
Where does Forbion Growth Opportunities Fund III Cooperatief U.A. file Form 4?
Forbion Growth Opportunities Fund III Cooperatief U.A. has filed Form 4 at BRVE (Braveheart Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.